Skip to content
Disclosery

Decheng Capital Management III (Cayman), LLC

Follow

13F filer, CIK 1747821, Grand Cayman, Cayman Islands

Decheng Capital Management III (Cayman), LLC reported $299,635,284 across 26 holdings for the quarter ended 2023-09-30, in a 13F-HR/A filed 2023-12-12. Its ten largest share positions make up 79.17% of the portfolio.

Filed (acceptance time not in the bulk data set), ingested 13F-HR/A 0001104659-23-125265

Period
2023-09-30
Reported value
$300M
Holdings
26
Top 10 weight
79.17%
New
9
Sold out
8

Largest buys vs the previous quarter

SecurityShares changeApprox. value
ALPINE IMMUNE SCIENCES INCnew+6,708,288$76.8M
ROIVnew+1,459,700$17M
AURAadded+869,790$13.6M
LNTHnew+142,196$9.88M
IMMUNOGEN INCnew+415,880$6.6M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
Alabama Power 5.20% Div Qua…exited-6,708,288-$69M
ROIVANT SCIENCES LTDexited-1,459,700-$14.7M
BeyondSpring Inc.exited-4,958,143-$5.85M
SEATTLE GENETICS INCexited-23,014-$4.43M
AtriCure Inc.exited-46,259-$2.28M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q3 2023

Share positions as resolved from 13F-HR/A 0001104659-23-125265, largest first. % of portfolio is the value over $299,635,284, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
ALPINE IMMUNE SCIENCES INCALPINE IMMUNE SCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q4: not loaded; 2022Q1: 4,708,288 shares; 2022Q2: 4,708,288 shares; 2022Q3: 6,708,288 shares; 2022Q4: not reported; 2023Q1: not reported; 2023Q2: not reported; 2023Q3: 6,708,288 shares 6,708,288$76.8M25.63%new
ZNTLZENTALIS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q4: not loaded; 2022Q1: not reported; 2022Q2: 1,824,583 shares; 2022Q3: 1,824,583 shares; 2022Q4: 1,824,583 shares; 2023Q1: 1,824,583 shares; 2023Q2: 2,099,583 shares; 2023Q3: 2,099,583 shares 2,099,583$42.1M14.06%0Timeline
AURAAURA BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q4: not loaded; 2022Q1: 210,000 shares; 2022Q2: 210,000 shares; 2022Q3: 210,000 shares; 2022Q4: 293,333 shares; 2023Q1: 293,333 shares; 2023Q2: 293,333 shares; 2023Q3: 1,163,123 shares 1,163,123$18.2M6.09%+869,790Timeline
ROIVROIVANT SCIENCES LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q4: not loaded; 2022Q1: not reported; 2022Q2: not reported; 2022Q3: not reported; 2022Q4: not reported; 2023Q1: not reported; 2023Q2: not reported; 2023Q3: 1,459,700 shares 1,459,700$17M5.69%newTimeline
ACELYRIN INCACELYRIN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q4: not loaded; 2022Q1: not reported; 2022Q2: not reported; 2022Q3: not reported; 2022Q4: not reported; 2023Q1: not reported; 2023Q2: 1,554,417 shares; 2023Q3: 1,548,317 shares 1,548,317$15.7M5.26%-6,100
RCUSARCUS BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q4: not loaded; 2022Q1: 869,790 shares; 2022Q2: 869,790 shares; 2022Q3: 869,790 shares; 2022Q4: 869,790 shares; 2023Q1: 869,790 shares; 2023Q2: 869,790 shares; 2023Q3: 869,790 shares 869,790$15.6M5.21%0Timeline
TXG10X GENOMICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q4: not loaded; 2022Q1: 303,984 shares; 2022Q2: 303,984 shares; 2022Q3: 359,554 shares; 2022Q4: 359,554 shares; 2023Q1: 359,554 shares; 2023Q2: 359,554 shares; 2023Q3: 359,554 shares 359,554$14.8M4.95%0Timeline
ARGXARGENX SEQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q4: not loaded; 2022Q1: not reported; 2022Q2: not reported; 2022Q3: 5,529 shares; 2022Q4: 5,529 shares; 2023Q1: 27,429 shares; 2023Q2: 27,429 shares; 2023Q3: 27,429 shares 27,429$13.5M4.5%0Timeline
PACBPACIFIC BIOSCIENCES CALIF INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q4: not loaded; 2022Q1: 1,463,872 shares; 2022Q2: 1,463,872 shares; 2022Q3: 1,463,872 shares; 2022Q4: 1,463,872 shares; 2023Q1: 1,463,872 shares; 2023Q2: 1,463,872 shares; 2023Q3: 1,463,872 shares 1,463,872$12.2M4.08%0Timeline
ILMNILLUMINA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q4: not loaded; 2022Q1: 154,238 shares; 2022Q2: 154,238 shares; 2022Q3: 130,138 shares; 2022Q4: 80,859 shares; 2023Q1: 80,859 shares; 2023Q2: 80,859 shares; 2023Q3: 80,859 shares 80,859$11.1M3.7%0Timeline
LNTHLANTHEUS HLDGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q4: not loaded; 2022Q1: not reported; 2022Q2: not reported; 2022Q3: not reported; 2022Q4: not reported; 2023Q1: not reported; 2023Q2: not reported; 2023Q3: 142,196 shares 142,196$9.88M3.3%newTimeline
HORIZON THERAPEUTICS PLCHORIZON THERAPEUTICS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q4: not loaded; 2022Q1: not reported; 2022Q2: 55,400 shares; 2022Q3: 78,900 shares; 2022Q4: 78,900 shares; 2023Q1: 78,900 shares; 2023Q2: 78,900 shares; 2023Q3: 78,900 shares 78,900$9.13M3.05%0
PHATPHATHOM PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q4: not loaded; 2022Q1: not reported; 2022Q2: not reported; 2022Q3: not reported; 2022Q4: not reported; 2023Q1: not reported; 2023Q2: 850,000 shares; 2023Q3: 850,000 shares 850,000$8.81M2.94%0Timeline
IMMUNOGEN INCIMMUNOGEN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q4: not loaded; 2022Q1: not reported; 2022Q2: not reported; 2022Q3: not reported; 2022Q4: not reported; 2023Q1: not reported; 2023Q2: not reported; 2023Q3: 415,880 shares 415,880$6.6M2.2%new
SEAGEN INCSEAGEN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q4: not loaded; 2022Q1: not reported; 2022Q2: not reported; 2022Q3: not reported; 2022Q4: not reported; 2023Q1: not reported; 2023Q2: not reported; 2023Q3: 23,014 shares 23,014$4.88M1.63%new
HLTHQCUE HEALTH INC COM (DE)Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q4: not loaded; 2022Q1: 8,980,909 shares; 2022Q2: 8,980,909 shares; 2022Q3: 8,980,909 shares; 2022Q4: 8,980,909 shares; 2023Q1: 8,980,909 shares; 2023Q2: 8,980,909 shares; 2023Q3: 8,980,909 shares 8,980,909$3.97M1.32%0Timeline
BYSIBEYONDSPRING INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q4: not loaded; 2022Q1: 4,958,142 shares; 2022Q2: 4,958,142 shares; 2022Q3: 4,958,143 shares; 2022Q4: not reported; 2023Q1: 4,958,143 shares; 2023Q2: not reported; 2023Q3: 4,958,143 shares 4,958,143$3.97M1.32%newTimeline
TERNTERNS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q4: not loaded; 2022Q1: 714,285 shares; 2022Q2: 714,285 shares; 2022Q3: 714,285 shares; 2022Q4: 714,285 shares; 2023Q1: 714,285 shares; 2023Q2: 714,285 shares; 2023Q3: 714,285 shares 714,285$3.59M1.2%0Timeline
EQEQUILLIUM INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q4: not loaded; 2022Q1: 4,447,308 shares; 2022Q2: 4,447,308 shares; 2022Q3: 4,447,308 shares; 2022Q4: 4,447,308 shares; 2023Q1: 4,447,308 shares; 2023Q2: 4,447,308 shares; 2023Q3: 4,447,308 shares 4,447,308$3.29M1.1%0Timeline
WHWKWHITEHAWK THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q4: not loaded; 2022Q1: 526,329 shares; 2022Q2: 526,329 shares; 2022Q3: 526,329 shares; 2022Q4: 526,329 shares; 2023Q1: 526,329 shares; 2023Q2: 526,329 shares; 2023Q3: 526,329 shares 526,329$2.55M0.85%0Timeline
ATRCATRICURE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q4: not loaded; 2022Q1: not reported; 2022Q2: not reported; 2022Q3: not reported; 2022Q4: not reported; 2023Q1: 46,259 shares; 2023Q2: not reported; 2023Q3: 46,259 shares 46,259$2.03M0.68%newTimeline
SCYXSCYNEXIS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q4: not loaded; 2022Q1: 555,555 shares; 2022Q2: 555,555 shares; 2022Q3: 555,555 shares; 2022Q4: 555,555 shares; 2023Q1: 555,555 shares; 2023Q2: 555,555 shares; 2023Q3: 555,555 shares 555,555$1.27M0.42%0Timeline
Mersana Therapeutics IncMersana Therapeutics IncQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q4: not loaded; 2022Q1: 904,268 shares; 2022Q2: 904,268 shares; 2022Q3: 904,268 shares; 2022Q4: 904,268 shares; 2023Q1: 904,268 shares; 2023Q2: 904,268 shares; 2023Q3: 904,268 shares 904,268$1.15M0.38%0
PYXSPYXIS ONCOLOGY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q4: not loaded; 2022Q1: not reported; 2022Q2: not reported; 2022Q3: not reported; 2022Q4: not reported; 2023Q1: not reported; 2023Q2: not reported; 2023Q3: 326,810 shares 326,810$650K0.22%newTimeline
WGSGENEDX HOLDINGS CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q4: not loaded; 2022Q1: not reported; 2022Q2: not reported; 2022Q3: not reported; 2022Q4: not reported; 2023Q1: not reported; 2023Q2: not reported; 2023Q3: 103,604 shares 103,604$377K0.13%newTimeline
ADICET BIO INCADICET BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q4: not loaded; 2022Q1: 580,000 shares; 2022Q2: 580,000 shares; 2022Q3: 580,000 shares; 2022Q4: 580,000 shares; 2023Q1: 580,000 shares; 2023Q2: 505,668 shares; 2023Q3: 200,201 shares 200,201$274K0.09%-305,467

Sold out in Q3 2023

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
Alabama Power 5.20% Div Qua…Alabama Power 5.20% Div Qualif6,708,288$69Mshares
ROIVANT SCIENCES LTDROIVANT SCIENCES LTD1,459,700$14.7Mshares
BeyondSpring Inc.BeyondSpring Inc.4,958,143$5.85Mshares
SEATTLE GENETICS INCSEATTLE GENETICS INC23,014$4.43Mshares
AtriCure Inc.AtriCure Inc.46,259$2.28Mshares
Pyxis Oncology, Inc (former…Pyxis Oncology, Inc (formerly Ape…1,894,551$814Kshares
SEMA4 HOLDINGS CORPSEMA4 HOLDINGS CORP103,604$617Kshares
Ohr Pharmaceutical IncOhr Pharmaceutical Inc50,000$92.5Kshares

How Q3 2023 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001104659-23-117065 superseded2023-11-13acceptance time not in the bulk data set
13F-HR/A 0001104659-23-122012 supersededrestatement2023-11-29acceptance time not in the bulk data set
13F-HR/A 0001104659-23-125265 baserestatement2023-12-12acceptance time not in the bulk data set

Filings

Every filing of this filer: 13F reports and notices, the 13D and 13G it filed or is a reporting person of, and Forms 3, 4 and 5 it reported as an owner.

FilingSubjectFiledAcceptedIngested
13F-HR/A 0001104659-23-125265 Quarter ended 2023-09-302023-12-12acceptance time not in the bulk data set
13F-HR/A 0001104659-23-122012 Quarter ended 2023-09-302023-11-29acceptance time not in the bulk data set
13F-HR 0001104659-23-117065 Quarter ended 2023-09-302023-11-13acceptance time not in the bulk data set
13F-HR 0001104659-23-085148 Quarter ended 2023-06-302023-07-28acceptance time not in the bulk data set
13F-HR 0001104659-23-058221 Quarter ended 2023-03-312023-05-10acceptance time not in the bulk data set
13F-HR 0001104659-23-017522 Quarter ended 2022-12-312023-02-09acceptance time not in the bulk data set
13F-HR 0001104659-22-115855 Quarter ended 2022-09-302022-11-08acceptance time not in the bulk data set
13F-HR 0001104659-22-084797 Quarter ended 2022-06-302022-08-01acceptance time not in the bulk data set
13F-HR 0001104659-22-058170 Quarter ended 2022-03-312022-05-10acceptance time not in the bulk data set